IKOMA Takeharu 生駒丈晴

Researcher Number	10638290
Other IDs
Affiliation *help	2015 – 2018 : 神奈川歯科大学, 大学院歯学研究科, 助教 2014 – 2015 : 神奈川歯科大学, 歯学研究科(研究院), 助教 2013 : 神奈川歯科大学, 歯学部附属病院, その他
Review Section/Research Field	Principal Investigator Surgical dentistry Except Principal Investigator Surgical dentistry
Keywords	Principal Investigator CXCL14 / BRAK / サイトカイン / 血管新生 / 転写因子 / 血管新生阻害 / 抗腫瘍効果 / 細胞分化 / 血管新生抑制 Except Principal Investigator セツキシマブ … More

癌の新生血管を正常化させるサイトカインCXCL14の臨床的意義Principal InvestigatorOngoing
- Principal Investigator
  
  生駒丈晴
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Surgical dentistry
- Research Institution
  Kanagawa Dental College
Clinical application of BRAK that is anti-angiogenic agentPrincipal Investigator
- Principal Investigator
  
  Ikoma Takeharu
- Project Period (FY)
  2015 – 2016
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Surgical dentistry
- Research Institution
  Kanagawa Dental College
Elucidation of Epigenetics in Head and Neck Squamous Cell Carcinoma.
- Principal Investigator
  
  Kubota Eiro
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Surgical dentistry
- Research Institution
  Kanagawa Dental College
Search of transcription factor for BRAK by using new method in Head and neck carcinomaPrincipal Investigator
- Principal Investigator
  
  IKOMA Takeharu
- Project Period (FY)
  2013 – 2014
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Surgical dentistry
- Research Institution
  Kanagawa Dental College

All 2016 2015 2014 2013 Other

All Journal Article Presentation

[Journal Article] Expression of the chemokine CXCL14 and cetuximab-dependent tumour suppression in head and neck squamous cell carcinoma.2016
- Author(s)
  Kondo T, Ozawa S, Ikoma T, Yang XY, Kanamori K, Suzuki K, Iwabuchi H, Maehata Y, Miyamoto C, Taguchi T, Kiyono T, Kubota E, Hata RI
- Journal Title
  
  Oncogenesis
  
  Volume : 5
- Open Access / Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K20567
[Journal Article] Fasudil, a Rho kinase inhibitor, suppresses tumor growth by inducing CXCL14/BRAK in head and neck squamous cell carcinoma.2014
- Author(s)
  Chihiro MIYAMOTO, Yojiro MAEHATA, Kazuhiko MOTOHASHI, Shigeyuki OZAWA, Takeharu IKOMA, Kouki HIDAKA, Satoko WADA-TAKAHASHI, Shun-Suke TAKAHASHI, Fumihiko YOSHINO, Ayaka YOSHIDA, Eiro KUBOTA, Ryu-Ichiro HATA, Masaichi-Chang-il LEE
- Journal Title
  
  Biomedical Research
  
  Volume : 35 Pages : 381-388
- Peer Reviewed / Open Access / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-25293414, KAKENHI-PROJECT-25861982
[Presentation] Is chemokine CXCL14, a multi-step tumor suppressor, a differentiation regulator of squamous epithelial cells ?2016
- Author(s)
  T. Ikoma, X. Yang, S. Ozawa, Y. Maehata, R. Hata
- Organizer
  歯科基礎医学会
- Place of Presentation
  札幌
- Year and Date
  2016-08-25
- Data Source
  KAKENHI-PROJECT-15K20567
[Presentation] Expression of the chemokine CXCL14 is a predictive biomarker for Cetuximab-dependent tumor supression.2015
- Author(s)
  生駒　丈晴
- Organizer
  歯科基礎医学会
- Place of Presentation
  新潟
- Year and Date
  2015-09-11
- Data Source
  KAKENHI-PROJECT-15K20567
[Presentation] セツキシマブによる抗腫瘍性ケモカインBRAKの発現上昇メカニズムの解明2013
- Author(s)
  小澤重幸、近藤忠稚、生駒丈晴、鈴木健司、久保田英朗
- Organizer
  日本口腔外科学会
- Place of Presentation
  福岡国際会議場
- Data Source
  KAKENHI-PROJECT-25861982
[Presentation] CXCL14のメチル化異常に着目したセツキシマブの抗腫瘍効果判定のための基礎研究
- Author(s)
  近藤忠稚、小澤重幸、生駒丈晴、鈴木健司、久保田英朗
- Organizer
  日本口腔外科学会総会・学術大会
- Place of Presentation
  千葉　(幕張メッセ)
- Year and Date
  2014-10-17 – 2014-10-19
- Data Source
  KAKENHI-PROJECT-25293414
[Presentation] CXCL14のメチル化異常に着目したセツキシマブの抗腫瘍効果判定のための基礎研究
- Author(s)
  近藤忠稚、小澤重幸、生駒丈晴、鈴木健司、久保田英朗
- Organizer
  日本口腔外科学会総会・学術大会
- Place of Presentation
  千葉　(幕張メッセ)
- Year and Date
  2014-10-17 – 2014-10-19
- Data Source
  KAKENHI-PROJECT-25861982

1. Kubota Eiro (50170030)

# of Collaborated Projects : 1results

# of Collaborated Products : 2results
2. KONDO TADANORI (00587727)

# of Collaborated Projects : 1results

# of Collaborated Products : 1results
3. OZAWA SHIGEYUKI (40434394)

# of Collaborated Projects : 1results

# of Collaborated Products : 2results
4. SUZUKI KENJI (80350536)

# of Collaborated Projects : 1results

# of Collaborated Products : 1results
5. MAEHATA YOUJIRO (80410009)

# of Collaborated Projects : 1results

# of Collaborated Products : 1results
6. 小林優 (00162024)

# of Collaborated Projects : 1results

# of Collaborated Products : 0results

IKOMA Takeharu 生駒 丈晴

Research Projects

Research Products

Co-Researchers

癌の新生血管を正常化させるサイトカインCXCL14の臨床的意義Principal InvestigatorOngoing

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Clinical application of BRAK that is anti-angiogenic agentPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Elucidation of Epigenetics in Head and Neck Squamous Cell Carcinoma.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Search of transcription factor for BRAK by using new method in Head and neck carcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Expression of the chemokine CXCL14 and cetuximab-dependent tumour suppression in head and neck squamous cell carcinoma.2016

Author(s)

Journal Title

Data Source

[Journal Article] Fasudil, a Rho kinase inhibitor, suppresses tumor growth by inducing CXCL14/BRAK in head and neck squamous cell carcinoma.2014

Author(s)

Journal Title

Data Source

[Presentation] Is chemokine CXCL14, a multi-step tumor suppressor, a differentiation regulator of squamous epithelial cells ?2016

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Expression of the chemokine CXCL14 is a predictive biomarker for Cetuximab-dependent tumor supression.2015

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] セツキシマブによる抗腫瘍性ケモカインBRAKの発現上昇メカニズムの解明2013

Author(s)

Organizer

Place of Presentation

Data Source

[Presentation] CXCL14のメチル化異常に着目したセツキシマブの抗腫瘍効果判定のための基礎研究

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] CXCL14のメチル化異常に着目したセツキシマブの抗腫瘍効果判定のための基礎研究

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

IKOMA Takeharu 生駒丈晴